Synthesis of novel 1-phenyl-benzopyrrolizidin-3-one derivatives and evaluation of their cytoneuroprotective effects against NMDA-induced injury in PC12 cells

Bioorg Med Chem. 2022 Apr 1:59:116675. doi: 10.1016/j.bmc.2022.116675. Epub 2022 Feb 18.

Abstract

A range of novel 1-phenyl-benzopyrrolizidin-3-one derivatives were synthesized and evaluated for neuroprotective effects against N-methyl-ᴅ-aspartate (NMDA)-induced injury in PC12 cells. Interestingly, derivatives that 1-phenyl moiety bearing electron-donating group, especially benzyloxy, and the trans-forms exhibited better protective activity against NMDA-induced neurotoxicity. Compound 11 m demonstrated the best neuroprotective potency and shown a dose-dependent prevention. The increased intracellular calcium (Ca2+) influx caused by NMDA in PC12 cells was reversed in the case of compound 11 m pretreatment at 15 μM. These results suggested that the synthesized 1-phenyl-benzopyrrolizidin-3-one derivatives exerted neuroprotective effect on NMDA-induced excitotoxicity in PC12 cells associated with inhibition of Ca2+ overload and can be further optimized for the development of neuroprotective agents.

Keywords: 1-Phenyl-benzopyrrolizidin-3-one; Excitotoxicity; N-methyl-ᴅ-aspartate; Neuroprotective effect; PC12 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / metabolism
  • N-Methylaspartate* / toxicity
  • Neuroprotective Agents* / pharmacology
  • PC12 Cells
  • Rats
  • Receptors, N-Methyl-D-Aspartate

Substances

  • Neuroprotective Agents
  • Receptors, N-Methyl-D-Aspartate
  • N-Methylaspartate
  • Calcium